According to data published by some experts, more than nine out of ten cases of tuberculosis, which kills 1.8 million people each year, could be averted by 2050 with better testing, drugs and vaccines.

Lesotho Health Minister Mphu Ramatlapeng at discussion in Geneva, where the report was unveiled at the World Health Organisation (WHO) mentioned that nowadays tuberculosis is outmoded.
Some 36 million people infected with TB during 1995-2008 were cured and incidence of the lung-wasting disease has begun to move back, but only by about one percent per year.

It’s registered that he majority of cases, more than 80 percent occur in only 22 countries, including nine in Africa, 11 in Asia, and Russia.

Revealing rates have enhanced over the last 15 years, but nearly 40 percent of active infections in those nations still go untreated.

The research has demonstrated that only a quarter of the estimated 1.4 million people infected with both tuberculosis and HIV/AIDS have been recognized. HIV increases the risk of TB 20 fold.
Up to two-thirds of cases in South Africa and Zimbabwe, for instance, are thought to be caused by HIV co-infection.

Frequent testing for HIV and the early start of antiretroviral treatment would help out to cut frequency by reducing the number of people with compromised immune systems.

Most types of tuberculosis can be treated with ten euros (13 dollars) worth of medicine if it is diagnosed early.

But when patients are unsuccessful to complete a treatment, the Mycobacterium tuberculosis germ that causes the disease develops a fight to frontline drugs such as isoniazid and rifampicin.

Treating the new superbugs costs thousands of dollars (euros) and can take a period of up to two years, and even then may fail.
The future option of strains that are completely resistant to all anti-tuberculosis drugs is not unthinkable.

In 2008, some 440,000 cases of MDR-TB occurred all over the world, half of them in China and India. Only seven percent, though, of these infections were cured. Turning back the tide on TB will need boosting basic health care infrastructure and targeted prevention measures, including enhanced vaccines, better use of antibiotics and decrease of danger features.